Patrys Ltd has released a press release.
Appendix 4D - Half Year Accounts - 31 December 2018
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Patrys
- Appendix 4C - Quarterly - 31 December 2018
- PAT-DX1 Suppresses Breast Cancer Brain Metastases
- Appendix 4C - Quarterly - 30 September 2018
- Settlement of Manufacturing Claims
- PAT-DX1 Clinical Target Indications Confirmed
Later from Patrys
- Market Update
- Appendix 4C - Quarterly - 31 March 2019
- PAT-DX1 Reduces Brain Metastases, Enhances Radiation Therapy
- Europe grants patent for Deoxymab 3E10
- PAT-DX1 significantly improves survival in aggressive GBM
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys